Montelukast Asthmatic Smoker Study
Phase 3
Completed
- Conditions
- Health Condition 1: null- Chronic Asthma Who Smoke Cigarettes.Health Condition 2: J989- Respiratory disorder, unspecified
- Registration Number
- CTRI/2009/091/000118
- Lead Sponsor
- Merck Co Inc
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 1000
Inclusion Criteria
Patients with chronic asthma who actively smoke at least 0.5 to no more than 2 packs of cigarettes a day
Exclusion Criteria
Patient can not have a diagnosis of Chronic Obstructive Pulmonary Disease (COPD) or emphysema
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of asthma-control days over the 6-month treatment periodTimepoint: Time Frame: 6 months [ Designated as safety issue: No ] <br/ ><br>
- Secondary Outcome Measures
Name Time Method AM Peak Expiratory Flow Rate (PEFR) and daytime symptom score over the 6-month treatment periodTimepoint: Time Frame: 6 months [ Designated as safety issue: No ]